Pages that link to "Q36448817"

The following pages link to HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy (Q36448817):

Displaying 39 items.

• Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems (Q26798467) (← links)
• Prostate cancer relevant antigens and enzymes for targeted drug delivery (Q27013843) (← links)
• Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer (Q33681168) (← links)
• Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic (Q33911056) (← links)
• Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant (Q33913444) (← links)
• Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy (Q34005639) (← links)
• The role of HER2 in cancer therapy and targeted drug delivery (Q34054213) (← links)
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (Q34447986) (← links)
• Affibody-based nanoprobes for HER2-expressing cell and tumor imaging (Q34545516) (← links)
• Hyperthermia-triggered intracellular delivery of anticancer agent to HER2 cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2 affisomes) (Q35104928) (← links)
• Improved tumor targeting of polymer-based nanovesicles using polymer-lipid blends (Q35399928) (← links)
• A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]. (Q35914149) (← links)
• Affibody‐Functionalized Gold–Silica Nanoparticles for Raman Molecular Imaging of the Epidermal Growth Factor Receptor (Q36066747) (← links)
• Nanotechnology-based approaches in anticancer research (Q36168983) (← links)
• Biotargeted nanomedicines for cancer: six tenets before you begin (Q36814280) (← links)
• Targeted polymeric therapeutic nanoparticles: design, development and clinical translation (Q36934007) (← links)
• Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide). (Q37056787) (← links)
• Small-molecule delivery by nanoparticles for anticancer therapy (Q37059874) (← links)
• Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors (Q37624379) (← links)
• Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. (Q37730252) (← links)
• Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies (Q37864159) (← links)
• Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. (Q37972851) (← links)
• Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. (Q38067265) (← links)
• Intelligent drug-delivery devices based on micro- and nano-technologies (Q38074464) (← links)
• Bioavailability of phytochemicals and its enhancement by drug delivery systems (Q38084084) (← links)
• Cellular uptake of nanoparticles: journey inside the cell. (Q38557482) (← links)
• Targeted nanotechnologies for cancer intervention: a patent review (2010-2016). (Q38670236) (← links)
• Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice? (Q38806793) (← links)
• Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. (Q38818802) (← links)
• Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment (Q38914616) (← links)
• Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy (Q39028976) (← links)
• Improved Targeting of Cancers with Nanotherapeutics (Q39114835) (← links)
• Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide–affibody bioconjugate (Q39423844) (← links)
• Caleosin-assembled oil bodies as a potential delivery nanocarrier (Q39435599) (← links)
• Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery (Q39436965) (← links)
• Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles (Q39527615) (← links)
• Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu‐positive tumor cells (Q39588838) (← links)
• Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells (Q90835372) (← links)
• Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance (Q99712238) (← links)